These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
760 related articles for article (PubMed ID: 35781817)
41. Mechanisms of Xiaochaihu Decoction on Treating Hepatic Fibrosis Explored by Network Pharmacology. Qiang R; Zhang Y; Wang Y Dis Markers; 2022; 2022():8925637. PubMed ID: 36246566 [TBL] [Abstract][Full Text] [Related]
42. Identifying cancer-related molecular targets of Nandina domestica Thunb. by network pharmacology-based analysis in combination with chemical profiling and molecular docking studies. Taha KF; Khalil M; Abubakr MS; Shawky E J Ethnopharmacol; 2020 Mar; 249():112413. PubMed ID: 31760157 [TBL] [Abstract][Full Text] [Related]
43. Integrating UPLC-Q-Exactive Orbitrap/MS, network pharmacology and experimental validation to reveal the potential mechanism of Tibetan medicine Rhodiola granules in improving myocardial ischemia-reperfusion injury. Xing N; Qin J; Ren D; Du Q; Li Y; Mi J; Zhang F; Ai L; Zhang S; Zhang Y; Wang S J Ethnopharmacol; 2023 Oct; 314():116572. PubMed ID: 37201662 [TBL] [Abstract][Full Text] [Related]
44. Uncovering the action mechanism of Shenqi Tiaoshen formula in the treatment of chronic obstructive pulmonary disease through network pharmacology, molecular docking, and experimental verification. Qinjun Y; Dandan Y; Hui W; Yating G; Xinheng W; Di WU; Jiabing T; Chuanbo W; Zegeng LI J Tradit Chin Med; 2024 Aug; 44(4):770-783. PubMed ID: 39066538 [TBL] [Abstract][Full Text] [Related]
45. The active ingredients and mechanisms of Longchai Jiangxue Formula in treating PV, based on UPLC/Q-TOF-MS/MS, systematic pharmacology, and molecular biology validation. Ming J; Liu W; Wu H; Li Y; Yang E; Wang Z; Xiao H; Quan R; Hu X Biomed Pharmacother; 2021 Aug; 140():111767. PubMed ID: 34058439 [TBL] [Abstract][Full Text] [Related]
46. Exploring the potential mechanism and molecular targets of Taohong Siwu Decoction against deep vein thrombosis based on network pharmacology and analysis docking. Fan W; Liu J; Liu Q Medicine (Baltimore); 2024 Jan; 103(2):e36220. PubMed ID: 38215128 [TBL] [Abstract][Full Text] [Related]
47. [Mechanism of Qingwei Powder in treatment of periodontitis based on UPLC-Q-TOF-MS, GC-MS, network pharmacology and molecular docking]. Meng Y; Jiang ZT; Yan GJ; Shen J; Sun KP; Wang YY; Cao JN; Xia MY; Pan JH Zhongguo Zhong Yao Za Zhi; 2022 May; 47(10):2778-2787. PubMed ID: 35718498 [TBL] [Abstract][Full Text] [Related]
48. Potential molecular mechanism of the Xiexin capsule in the intervention of dyslipidemia based on bioinformatics and molecular docking. Yao K; Cai H; Wang Y; Cheng S; Liu Q; Zhang D; Chen Q; Chen X Nutr Hosp; 2022 Jun; 39(3):569-579. PubMed ID: 35227068 [TBL] [Abstract][Full Text] [Related]
49. Uncovering the Mechanism of Chinese Hawthorn Leaf on Myocardial Ischemia Based on Network Pharmacology, Molecular Docking Verification, and In Vitro Studies. Gao J; Wang Y; Xiong H; Zhao S; He M; He M; Pan H Cardiovasc Toxicol; 2024 Feb; 24(2):171-183. PubMed ID: 38376772 [TBL] [Abstract][Full Text] [Related]
50. Xiao-Luo-Wan treats propylthiouracil-induced goiter with hypothyroidism in rats through the PI3K-AKT/RAS pathways based on UPLC/MS and network pharmacology. Dong S; Liu Q; Jiang M; Ma Q; Huang Q; Liu T; Li Y; Ni L; Shi Y J Ethnopharmacol; 2022 May; 289():115045. PubMed ID: 35101570 [TBL] [Abstract][Full Text] [Related]
51. [Mechanism of Sijunzi Decoction in treatment of Alzheimer's disease based on UPLC-Q-TOF-MS, network pharmacology, and experimental verification]. Cai KZ; Zheng Q; Zhu XD; Wei SF; Wu MQ; Xiong H; Zhao HT Zhongguo Zhong Yao Za Zhi; 2023 Mar; 48(6):1620-1631. PubMed ID: 37005850 [TBL] [Abstract][Full Text] [Related]
52. Network pharmacology to explore the molecular mechanisms of Prunella vulgaris for treating thyroid cancer. Zhang Z; Zhou J; Guo R; Zhou Q; Wang L; Xiang X; Ge S; Cui Z Medicine (Baltimore); 2023 Nov; 102(45):e34871. PubMed ID: 37960775 [TBL] [Abstract][Full Text] [Related]
53. Network Pharmacology-Based and Molecular Docking-Based Analysis of Suanzaoren Decoction for the Treatment of Parkinson's Disease with Sleep Disorder. Liu YY; Yu LH; Zhang J; Xie DJ; Zhang XX; Yu JM Biomed Res Int; 2021; 2021():1752570. PubMed ID: 34660782 [TBL] [Abstract][Full Text] [Related]
54. Bioactive constituents and the molecular mechanism of Curcumae Rhizoma in the treatment of primary dysmenorrhea based on network pharmacology and molecular docking. Tong H; Yu M; Fei C; Ji D; Dong J; Su L; Gu W; Mao C; Li L; Bian Z; Lu T; Hao M; Zeng B Phytomedicine; 2021 Jun; 86():153558. PubMed ID: 33866197 [TBL] [Abstract][Full Text] [Related]
55. Investigating the active components of Huatan Tongjing decoction for the treatment of polycystic ovary syndrome via network pharmacology. Yu J; Fu Y; Zeng L; Zheng Y Chem Biol Drug Des; 2022 Oct; 100(4):515-524. PubMed ID: 35822313 [TBL] [Abstract][Full Text] [Related]
56. Network pharmacology and molecular docking study on the effect of Kaempferol in treatment of metabolic associated fatty liver disease. Kaixuan Z; Dong Z; Huiwei B; Lijing LI J Tradit Chin Med; 2022 Oct; 42(5):788-794. PubMed ID: 36083487 [TBL] [Abstract][Full Text] [Related]
57. Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis. Liu J; Liu J; Tong X; Peng W; Wei S; Sun T; Wang Y; Zhang B; Li W Drug Des Devel Ther; 2021; 15():3255-3276. PubMed ID: 34349502 [TBL] [Abstract][Full Text] [Related]
58. Combining network pharmacology, machine learning, molecular docking and molecular dynamic to explore the mechanism of Chufeng Qingpi decoction in treating schistosomiasis. Liu M; Wang Y; Deng W; Xie J; He Y; Wang L; Zhang J; Cui M Front Cell Infect Microbiol; 2024; 14():1453529. PubMed ID: 39310787 [TBL] [Abstract][Full Text] [Related]
59. Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy. Ma Y; Deng Y; Li N; Dong A; Li H; Chen S; Zhang S; Zhang M J Ethnopharmacol; 2023 Feb; 302(Pt A):115768. PubMed ID: 36280016 [TBL] [Abstract][Full Text] [Related]
60. Exploring the therapeutic mechanism of Banxia Xiexin Decoction in mild cognitive impairment and diabetes mellitus: a network pharmacology approach. Li C; Yang W; Meng Y; Feng L; Sun L; Li Z; Liu X; Li M Metab Brain Dis; 2023 Oct; 38(7):2315-2325. PubMed ID: 37556042 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]